GLOW 70 mg Research Blend
A 70 mg blend listed as 50 mg GHK-Cu, 10 mg BPC-157, and 10 mg TB-4.
Whole vial: 70 mg Vial math ↓
Why people look it up
GLOW is marketed as a skin-and-recovery blend because it combines GHK-Cu, BPC-157, and a thymosin-related ingredient.
Skin appearance from the blendINSUFFICIENT EVIDENCE
Topical GHK-Cu data cannot be transferred to the full dry-vial mixture. Read source ↗
Soft-tissue recovery from the blendINSUFFICIENT EVIDENCE
BPC-157 animal results do not test the combined formulation in humans. Read source ↗
Combined or synergistic effectINSUFFICIENT EVIDENCE
The ingredient list is not a clinical study of the mixture. Read source ↗
The labels show the evidence for each claim. Open a row for its source.
Dosage at a glance
Dosage source summary
- How often
- Once daily in the source chart
- Time on / time off
- Four-week example; no validated low/middle/high bands.
- Route
- Subcutaneous in the chart
A 50/10/10 blend example. The source gives one amount, so no middle or higher amount has been invented.
These source amounts do not establish a safe human dose for a research vial.
Sources & individual reports
- PeptideDosages GLOW 70 mg published chart; reviewed October 18, 2026
A 50/10/10 blend example. The source gives one amount, so no middle or higher amount has been invented. Source check: 2026-10-18.
Source coverage: 1 reviewed public account. Not a community consensus.
Report 1 ↗Secondhand / firsthand status unclear
- Amount reported
- about 1.67 mg GHK-Cu plus 0.33 mg each BPC-157 and thymosin component per stated 10 U
- How often reported
- not stated
- Reported duration / cycle
- recent start; duration not stated
- Route (how it was taken)
- injection implied; route not stated
What the account says: Poster described a spouse starting a 50/10/10 blend and gave the mixture arithmetic. The post alternated TB-4 and TB-500 wording, so the ingredient identity is unresolved.
Product match & source details
Product match: Reported 50 mg GHK-Cu / 10 mg BPC-157 / 10 mg TB-4; matches the named ratio but not a verified batch.
r/Peptidesource family-member account · Posted: date not independently verified · Reviewed: 2026-10-03.
How much agreement is there? One spouse-reported account uses a 50/10/10 ratio but switches between TB-4 and TB-500 wording. The exact molecular identity is unresolved; no reliable blend range is established.
Public sources last reviewed: 2026-10-03. Product identity and reported results were not independently verified. Source method →
Evidence, sources & vial math
What the research actually showsHuman studies, evidence limits and mechanisms
What has actually been studied?
Studies of individual ingredients cannot establish that the full 70 mg mixture works, or that its ingredients interact beneficially. The exact thymosin-related identity should be checked against the batch report.
Evidence limits: The finished blend has no independently checked human outcome or regimen here. Ingredient studies cannot validate the combination.
Product status: Research-vial listings are not FDA-approved medicines. Approved-use labels on this page refer only to the named finished prescription product.
Human research
No directly administered human outcome study of this exact GHK-Cu/BPC-157/full-length TB-4 blend was identified among the reviewed ingredient studies and product documentation. Ingredient findings cannot verify effects of the combined vial.
Reviewed cited studies and the linked product or regulator documentation; absence of an extracted trial is not proof that no study exists.
Study and prescription-product amounts describe those sources. They do not select an amount for an online research vial.
How researchers think it might work
This mixture puts three separately studied ingredients in one vial. There is no established mechanism or clinical benefit for the mixture itself.
Show scientific explanation
The product lists GHK-Cu, BPC-157 and full-length thymosin beta-4. Ingredient-level observations cannot demonstrate a combined mechanism, interaction or clinical effect. Full-length TB-4 must not be treated as the TB-500 fragment. Read supporting source ↗
Vial & syringe mathTurn the vial total and liquid volume into concentration and syringe units
Vial & syringe math
Change the vial total and final liquid volume to see what each U-100 syringe mark represents.
The starting 1 mL is a math example. Enter your final mixed volume to update the numbers.
100 U-100 syringe units = 1 mL. These results assume the labeled amount is evenly mixed through the final liquid volume.
Continue in the calculator →30-day arithmetic: 70 mg divided into 30 equal parts is 2.33 mg of the whole blend per part. This is not a dosing or stability recommendation. Open the 30-day planner →
About this listingResearch-use-only status, seller names and additional background
A research material is not intended for human use. Its name or lab report does not establish suitability for a person. What research use only means →
Compiled by PeptideWhy · Scientific sources last checked 2026-10-03 · Editorial policy · Corrections